78 related articles for article (PubMed ID: 14506752)
1. Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis.
Riva P; Crosti F; Orzan F; Dalprà L; Mortini P; Parafioriti A; Pollo B; Fuhrman Conti AM; Miozzo M; Larizza L
Int J Cancer; 2003 Nov; 107(3):493-7. PubMed ID: 14506752
[TBL] [Abstract][Full Text] [Related]
2. A tumor suppressor locus in familial and sporadic chordoma maps to 1p36.
Miozzo M; Dalprà L; Riva P; Volontà M; Macciardi F; Pericotti S; Tibiletti MG; Cerati M; Rohde K; Larizza L; Fuhrman Conti AM
Int J Cancer; 2000 Jul; 87(1):68-72. PubMed ID: 10861454
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.
Longoni M; Orzan F; Stroppi M; Boari N; Mortini P; Riva P
Neuro Oncol; 2008 Feb; 10(1):52-60. PubMed ID: 18094369
[TBL] [Abstract][Full Text] [Related]
4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
5. [Refined mapping of loss of heterozygosity of 1p36.33-36.31 in sporadic colorectal carcinoma].
Zhou CZ; Zheng HT; Qiu GQ; Zhang F; He L; Peng ZH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1804-7. PubMed ID: 17054854
[TBL] [Abstract][Full Text] [Related]
6. New candidate chromosomal regions for chordoma development.
Bayrakli F; Guney I; Kilic T; Ozek M; Pamir MN
Surg Neurol; 2007 Oct; 68(4):425-30; discussion 430. PubMed ID: 17714767
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.
Horbinski C; Oakley GJ; Cieply K; Mantha GS; Nikiforova MN; Dacic S; Seethala RR
Arch Pathol Lab Med; 2010 Aug; 134(8):1170-6. PubMed ID: 20670138
[TBL] [Abstract][Full Text] [Related]
8. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
Alholle A; Brini AT; Bauer J; Gharanei S; Niada S; Slater A; Gentle D; Maher ER; Jeys L; Grimer R; Sumathi VP; Latif F
Epigenetics; 2015; 10(3):213-20. PubMed ID: 25621392
[TBL] [Abstract][Full Text] [Related]
10. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region.
Fang W; Piao Z; Simon D; Sheu JC; Huang S
Genes Chromosomes Cancer; 2000 Jul; 28(3):269-75. PubMed ID: 10862032
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22.
Allan GJ; Cottrell S; Trowsdale J; Foulkes WD
Hum Mutat; 1994; 3(3):283-91. PubMed ID: 8019564
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma.
Cheung TH; Chung TK; Poon CS; Hampton GM; Wang VW; Wong YF
Cancer; 1999 Oct; 86(7):1294-8. PubMed ID: 10506716
[TBL] [Abstract][Full Text] [Related]
13. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors.
O'Leary T; Ernst S; Przygodzki R; Emory T; Sobin L
Lab Invest; 1999 Dec; 79(12):1461-7. PubMed ID: 10616197
[TBL] [Abstract][Full Text] [Related]
15. Narrowing of the regions of allelic losses of chromosome 1p36 in meningioma tissues by an improved SSCP analysis.
Guan Y; Hata N; Kuga D; Yoshimoto K; Mizoguchi M; Shono T; Suzuki SO; Tahira T; Kukita Y; Higasa K; Yokoyama N; Nagata S; Iwaki T; Sasaki T; Hayashi K
Int J Cancer; 2008 Apr; 122(8):1820-6. PubMed ID: 18092328
[TBL] [Abstract][Full Text] [Related]
16. Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33.
Kelley MJ; Korczak JF; Sheridan E; Yang X; Goldstein AM; Parry DM
Am J Hum Genet; 2001 Aug; 69(2):454-60. PubMed ID: 11452362
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival.
Ragnarsson G; Eiriksdottir G; Johannsdottir JT; Jonasson JG; Egilsson V; Ingvarsson S
Br J Cancer; 1999 Mar; 79(9-10):1468-74. PubMed ID: 10188892
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis of three variants of clival chordoma.
Gil Z; Fliss DM; Voskoboinik N; Leider-Trejo L; Spektor S; Yaron Y; Orr-Urtreger A
Cancer Genet Cytogenet; 2004 Oct; 154(2):124-30. PubMed ID: 15474147
[TBL] [Abstract][Full Text] [Related]
20. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
